Filed 26d ago· May 8, 2026
Donald J. Trump
RPOTUSFlorida
↑bought
Bristol-Myers Squibb
BMY
$15K-$50K
Trade dateMay 8, 2026
BRISTOL MYERS SQUIBB CO UNSOLICITED
Recent filings
Every politician trade, as it’s filed.
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.
Showing 1–63 of 63
Filed 4mo ago· Jan 15, 2026
28 days to disclose
Julie Johnson
DHouseTexas-32
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
−3.5% vs S&P 500
Trade dateDec 18, 2025
Common Stock
Filed 4mo ago· Jan 13, 2026
260 days to disclose · 215 past 45-day window
Julia Letlow
RHouseLouisiana-05
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
+7.2% vs S&P 500
Trade dateApr 28, 2025
Common Stock
Filed 4mo ago· Jan 13, 2026
447 days to disclose · 402 past 45-day windowJulia Letlow
RHouseLouisiana-05
↑bought
Bristol-Myers Squibb
BMY
$1K-$15K
+4.3% vs S&P 500
Trade dateOct 23, 2024
Common Stock
Filed 4mo ago· Jan 12, 2026
24 days to disclose
Gilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Bristol-Myers Squibb
BMY
$1K-$15K
+5.1% vs S&P 500
Trade dateDec 19, 2025
Common Stock
Filed 5mo ago· Dec 15, 2025
33 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↑bought
Bristol-Myers Squibb
BMY
$1K-$15K
+14.2% vs S&P 500
Trade dateNov 12, 2025
Common Stock
Filed 5mo ago· Dec 11, 2025
28 days to discloseJulie Johnson
DHouseTexas-32
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
−2.8% vs S&P 500
Trade dateNov 13, 2025
Common Stock
Filed 6mo ago· Nov 18, 2025
40 days to discloseGilbert Ray Cisneros Jr.
DHouseCalifornia-31
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
+3.0% vs S&P 500
Trade dateOct 9, 2025
Common Stock
Filed 8mo ago· Sep 12, 2025
318 days to disclose · 273 past 45-day window
Val T. Hoyle
DHouseOregon-04
↑bought
Bristol-Myers Squibb
BMY
$1K-$15K
+4.1% vs S&P 500
Trade dateOct 29, 2024
Common Stock
Filed 8mo ago· Sep 11, 2025
28 days to discloseJulie Johnson
DHouseTexas-32
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
+10.9% vs S&P 500
Trade dateAug 14, 2025
Common Stock
Filed 11mo ago· Jul 3, 2025
9 days to disclose
Virginia Foxx
RHouseNorth Carolina-05
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
+11.0% vs S&P 500
Trade dateJun 24, 2025
Common Stock
⚑ Pharmaceutical
Filed 11mo ago· Jun 22, 2025
41 days to disclose
Jefferson Shreve
RHouseIndiana-06
↓sold
Bristol-Myers Squibb
BMY
$15K-$50K
+9.2% vs S&P 500
Trade dateMay 12, 2025
Common Stock
Filed 1.1y ago· May 15, 2025
30 days to disclose
Tommy Tuberville
RSenateAlabama
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
+7.9% vs S&P 500
Trade dateApr 15, 2025
⚑ Pharmaceutical
Filed 1.1y ago· May 14, 2025
43 days to discloseJulie Johnson
DHouseTexas-32
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
+3.6% vs S&P 500
Trade dateApr 1, 2025
Common Stock
Filed 1.2y ago· Apr 8, 2025
12 days to disclose
Greg Landsman
DHouseOhio-01
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
+2.4% vs S&P 500
Trade dateMar 27, 2025
Common Stock
⚑ Pharmaceutical
Filed 1.3y ago· Feb 12, 2025
28 days to discloseJulie Johnson
DHouseTexas-32
↑bought
Bristol-Myers Squibb
BMY
$1K-$15K
−8.2% vs S&P 500
Trade dateJan 15, 2025
Common Stock
Filed 1.4y ago· Jan 6, 2025
31 days to discloseVirginia Foxx
RHouseNorth Carolina-05
↑bought
Bristol-Myers Squibb
BMY
$1K-$15K
−10.8% vs S&P 500
Trade dateDec 6, 2024
Common Stock
⚑ Pharmaceutical
Filed 1.8y ago· Sep 2, 2024
228 days to disclose · 183 past 45-day window
John James
RHouseMichigan-10
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
+6.6% vs S&P 500
Trade dateJan 18, 2024
Common Stock
⚑ Pharmaceutical
Filed 1.8y ago· Sep 2, 2024
297 days to disclose · 252 past 45-day windowJohn James
RHouseMichigan-10
↑bought
Bristol-Myers Squibb
BMY
$1K-$15K
−9.6% vs S&P 500
Trade dateNov 10, 2023
Common Stock
⚑ Pharmaceutical
Filed 2.1y ago· May 15, 2024
42 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
+24.9% vs S&P 500
Trade dateApr 3, 2024
⚑ Pharmaceutical
Filed 2.1y ago· May 15, 2024
42 days to discloseTommy Tuberville
RSenateAlabama
↑bought
Bristol-Myers Squibb
BMY
$1K-$15K
−24.9% vs S&P 500
Trade dateApr 3, 2024
Option⚑ Pharmaceutical
Filed 2.3y ago· Feb 14, 2024
42 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
+40.0% vs S&P 500
Trade dateJan 3, 2024
⚑ Pharmaceutical
Filed 2.4y ago· Jan 19, 2024
10 days to disclose
Rick Larsen
DHouseWashington-02
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
+5.8% vs S&P 500
Trade dateJan 9, 2024
Filed 2.5y ago· Dec 15, 2023
29 days to discloseTommy Tuberville
RSenateAlabama
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
+61.9% vs S&P 500
Trade dateNov 16, 2023
Option⚑ Pharmaceutical
Filed 2.5y ago· Nov 16, 2023
30 days to discloseTommy Tuberville
RSenateAlabama
↑bought
Bristol-Myers Squibb
BMY
$1K-$15K
−16.1% vs S&P 500
Trade dateOct 17, 2023
⚑ Pharmaceutical
Filed 2.6y ago· Nov 9, 2023
16 days to disclose
Greg Stanton
DHouseArizona-04
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
+16.3% vs S&P 500
Trade dateOct 24, 2023
Filed 2.6y ago· Nov 9, 2023
44 days to discloseGreg Stanton
DHouseArizona-04
↑bought
Bristol-Myers Squibb
BMY
$1K-$15K
−21.0% vs S&P 500
Trade dateSep 26, 2023
Filed 2.7y ago· Sep 22, 2023
31 days to disclose
Dan Sullivan
RSenateAlaska
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
+68.0% vs S&P 500
Trade dateAug 22, 2023
⚑ Pharmaceutical
Filed 2.7y ago· Sep 18, 2023
27 days to discloseDan Sullivan
RSenateAlaska
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
+68.0% vs S&P 500
Trade dateAug 22, 2023
⚑ Pharmaceutical
Filed 2.8y ago· Aug 13, 2023
32 days to disclose
Daniel S. Goldman
DHouseNew York-10
↓sold
Bristol-Myers Squibb
BMY
$15K-$50K
+14.5% vs S&P 500
Trade dateJul 12, 2023
Filed 3.0y ago· Jun 14, 2023
35 days to disclose
Shelley Moore Capito
RSenateWest Virginia
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
+87.2% vs S&P 500
Trade dateMay 10, 2023
⚑ Pharmaceutical
Filed 3.0y ago· May 26, 2023
912 days to disclose · 867 past 45-day windowRick Larsen
DHouseWashington-02
↑bought
Bristol-Myers Squibb
BMY
$1K-$15K
Trade dateNov 25, 2020
Filed 3.0y ago· May 19, 2023
39 days to discloseDaniel S. Goldman
DHouseNew York-10
↑bought
Bristol-Myers Squibb
BMY
$50K-$100K
−33.5% vs S&P 500
Trade dateApr 10, 2023
Filed 3.1y ago· Apr 17, 2023
41 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
+16.9% vs S&P 500
Trade dateMar 7, 2023
Filed 3.1y ago· Apr 17, 2023
42 days to discloseDaniel S. Goldman
DHouseNew York-10
↓sold
Bristol-Myers Squibb
BMY
$100K-$250K
+15.0% vs S&P 500
Trade dateMar 6, 2023
Filed 3.3y ago· Feb 13, 2023
34 days to discloseDan Sullivan
RSenateAlaska
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
+100.8% vs S&P 500
Trade dateJan 10, 2023
⚑ Pharmaceutical
Filed 3.4y ago· Dec 26, 2022
28 days to disclose
Nicholas V. Taylor
—HouseTexas-03
↓sold
Bristol-Myers Squibb
BMY
$100K-$250K
+9.1% vs S&P 500
Trade dateNov 28, 2022
Filed 3.5y ago· Dec 19, 2022
560 days to disclose · 515 past 45-day window
Thomas R. Suozzi
DHouseNew York-03
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
+21.2% vs S&P 500
Trade dateJun 7, 2021
2000084729 Bristol-Myers Squibb Company
⚑ Pharmaceutical
Filed 3.5y ago· Dec 19, 2022
563 days to disclose · 518 past 45-day windowThomas R. Suozzi
DHouseNew York-03
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
+21.6% vs S&P 500
Trade dateJun 4, 2021
2000084726 Bristol-Myers Squibb Company
⚑ Pharmaceutical
Filed 3.5y ago· Dec 19, 2022
872 days to disclose · 827 past 45-day windowThomas R. Suozzi
DHouseNew York-03
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
Trade dateJul 30, 2020
⚑ Pharmaceutical
Filed 3.5y ago· Dec 19, 2022
892 days to disclose · 847 past 45-day windowThomas R. Suozzi
DHouseNew York-03
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
Trade dateJul 10, 2020
⚑ Pharmaceutical
Filed 3.5y ago· Dec 19, 2022
1075 days to disclose · 1030 past 45-day windowThomas R. Suozzi
DHouseNew York-03
↓sold
Bristol-Myers Squibb
BMY
$15K-$50K
Trade dateJan 9, 2020
2000084548 Bristol-Myers Squibb Company
⚑ Pharmaceutical
Filed 3.5y ago· Dec 19, 2022
1351 days to disclose · 1306 past 45-day windowThomas R. Suozzi
DHouseNew York-03
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
Trade dateApr 8, 2019
2000084402 Bristol-Myers Squibb Company
⚑ Pharmaceutical
Filed 3.5y ago· Dec 19, 2022
1361 days to disclose · 1316 past 45-day windowThomas R. Suozzi
DHouseNew York-03
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
Trade dateMar 29, 2019
⚑ Pharmaceutical
Filed 3.5y ago· Dec 19, 2022
1707 days to disclose · 1662 past 45-day windowThomas R. Suozzi
DHouseNew York-03
↑bought
Bristol-Myers Squibb
BMY
$1K-$15K
Trade dateApr 17, 2018
⚑ Pharmaceutical
Filed 3.8y ago· Sep 2, 2022
296 days to disclose · 251 past 45-day window
Carol D. Miller
RHouseWest Virginia-01
↓sold
Bristol-Myers Squibb
BMY
$15K-$50K
+55.1% vs S&P 500
Trade dateNov 10, 2021
⚑ Pharmaceutical
Filed 3.8y ago· Aug 10, 2022
26 days to disclose
Kathy Manning
DHouseNorth Carolina-06
↑bought
Bristol-Myers Squibb
BMY
$1K-$15K
−41.8% vs S&P 500
Trade dateJul 15, 2022
Filed 3.9y ago· Jul 15, 2022
28 days to discloseShelley Moore Capito
RSenateWest Virginia
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
+110.8% vs S&P 500
Trade dateJun 17, 2022
⚑ Pharmaceutical
Filed 4.1y ago· Apr 19, 2022
34 days to disclose
John H. Rutherford
RHouseFlorida-05
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
+10.8% vs S&P 500
Trade dateMar 16, 2022
Filed 4.3y ago· Feb 3, 2022
16 days to disclose
Thomas R Carper
DSenateDelaware
↑bought
Bristol-Myers Squibb
BMY
$1K-$15K
−65.9% vs S&P 500
Trade dateJan 18, 2022
Filed 4.5y ago· Dec 4, 2021
5 days to discloseThomas R Carper
DSenateDelaware
↑bought
Bristol-Myers Squibb
BMY
$1K-$15K
−46.2% vs S&P 500
Trade dateNov 29, 2021
Filed 4.6y ago· Nov 4, 2021
42 days to disclose
John A. Yarmuth
—HouseKentucky-03
↑bought
Bristol-Myers Squibb
BMY
$1K-$15K
−21.9% vs S&P 500
Trade dateSep 23, 2021
Filed 4.6y ago· Nov 4, 2021
43 days to discloseJohn A. Yarmuth
—HouseKentucky-03
↑bought
Bristol-Myers Squibb
BMY
$1K-$15K
−22.0% vs S&P 500
Trade dateSep 22, 2021
Filed 4.7y ago· Sep 23, 2021
108 days to disclose · 63 past 45-day windowThomas R. Suozzi
DHouseNew York-03
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
+21.2% vs S&P 500
Trade dateJun 7, 2021
⚑ Pharmaceutical
Filed 4.7y ago· Sep 23, 2021
111 days to disclose · 66 past 45-day windowThomas R. Suozzi
DHouseNew York-03
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
+21.6% vs S&P 500
Trade dateJun 4, 2021
⚑ Pharmaceutical
Filed 4.7y ago· Sep 23, 2021
623 days to disclose · 578 past 45-day windowThomas R. Suozzi
DHouseNew York-03
↓sold
Bristol-Myers Squibb
BMY
$15K-$50K
Trade dateJan 9, 2020
⚑ Pharmaceutical
Filed 4.7y ago· Sep 23, 2021
623 days to disclose · 578 past 45-day windowThomas R. Suozzi
DHouseNew York-03
↑bought
Bristol-Myers Squibb
BMY
$50K-$100K
Trade dateJan 9, 2020
⚑ Pharmaceutical
Filed 4.7y ago· Sep 23, 2021
899 days to disclose · 854 past 45-day windowThomas R. Suozzi
DHouseNew York-03
↓sold
Bristol-Myers Squibb
BMY
$15K-$50K
Trade dateApr 8, 2019
⚑ Pharmaceutical
Filed 4.7y ago· Sep 23, 2021
1088 days to disclose · 1043 past 45-day windowThomas R. Suozzi
DHouseNew York-03
↑bought
Bristol-Myers Squibb
BMY
$15K-$50K
Trade dateOct 1, 2018
⚑ Pharmaceutical
Filed 4.8y ago· Aug 13, 2021
28 days to discloseTommy Tuberville
RSenateAlabama
↑bought
Bristol-Myers Squibb
BMY
$15K-$50K
Trade dateJul 16, 2021
⚑ Pharmaceutical
Filed 5.1y ago· May 2, 2021
381 days to disclose · 336 past 45-day windowDJ
David A Perdue , Jr
—Senate
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
Trade dateApr 16, 2020
Filed 5.1y ago· May 2, 2021
383 days to disclose · 338 past 45-day windowDJ
David A Perdue , Jr
—Senate
↓sold
Bristol-Myers Squibb
BMY
$15K-$50K
Trade dateApr 14, 2020
Filed 5.1y ago· May 2, 2021
383 days to disclose · 338 past 45-day windowDJ
David A Perdue , Jr
—Senate
↓sold
Bristol-Myers Squibb
BMY
$15K-$50K
Trade dateApr 14, 2020
| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
May 8, 2026 26d ago | Donald J. Trump RPOTUSFlorida | ↑bought | Bristol-Myers Squibb BMY BRISTOL MYERS SQUIBB CO UNSOLICITED | May 8, 2026 | price pending | $15K-$50K midpoint $32.5K |
Jan 15, 2026 4mo ago | Julie Johnson DHouseTexas-32 | ↓sold | Bristol-Myers Squibb BMY Common Stock | Dec 18, 2025 28 days to disclose | Flat·+0.0% −3.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 13, 2026 4mo ago | Julia Letlow RHouseLouisiana-05 | ↓sold | Bristol-Myers Squibb BMY Common Stock | Apr 28, 2025 260 days to disclose · 215 past 45-day window | Flat·+0.0% +7.2% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 13, 2026 4mo ago | Julia Letlow RHouseLouisiana-05 | ↑bought | Bristol-Myers Squibb BMY Common Stock | Oct 23, 2024 447 days to disclose · 402 past 45-day window | Good buy·+$245+3.1% +4.3% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 12, 2026 4mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Bristol-Myers Squibb BMY Common Stock | Dec 19, 2025 24 days to disclose | Good buy·+$73+0.9% +5.1% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 15, 2025 5mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Bristol-Myers Squibb BMY Common Stock | Nov 12, 2025 33 days to disclose | Good buy·+$914+11.4% +14.2% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 11, 2025 5mo ago | Julie Johnson DHouseTexas-32 | ↓sold | Bristol-Myers Squibb BMY Common Stock | Nov 13, 2025 28 days to disclose | Flat·+0.0% −2.8% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 18, 2025 6mo ago | Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Bristol-Myers Squibb BMY Common Stock | Oct 9, 2025 40 days to disclose | Flat·+0.0% +3.0% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | Val T. Hoyle DHouseOregon-04 | ↑bought | Bristol-Myers Squibb BMY Common Stock | Oct 29, 2024 318 days to disclose · 273 past 45-day window | Good buy·+$333+4.2% +4.1% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 11, 2025 8mo ago | Julie Johnson DHouseTexas-32 | ↓sold | Bristol-Myers Squibb BMY Common Stock | Aug 14, 2025 28 days to disclose | Flat·+0.0% +10.9% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 3, 2025 11mo ago | Virginia Foxx RHouseNorth Carolina-05 | ↓sold | Bristol-Myers Squibb BMY Common Stock ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jun 24, 2025 9 days to disclose | Flat·+0.0% +11.0% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 22, 2025 11mo ago | Jefferson Shreve RHouseIndiana-06 | ↓sold | Bristol-Myers Squibb BMY Common Stock | May 12, 2025 41 days to disclose | Flat·+0.0% +9.2% vs S&P 500 | $15K-$50K midpoint $32.5K |
May 15, 2025 1.1y ago | Tommy Tuberville RSenateAlabama | ↓sold | Bristol-Myers Squibb BMY ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Apr 15, 2025 30 days to disclose | Flat·+0.0% +7.9% vs S&P 500 | $1K-$15K midpoint $8K |
May 14, 2025 1.1y ago | Julie Johnson DHouseTexas-32 | ↓sold | Bristol-Myers Squibb BMY Common Stock | Apr 1, 2025 43 days to disclose | Flat·+0.0% +3.6% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 8, 2025 1.2y ago | Greg Landsman DHouseOhio-01 | ↓sold | Bristol-Myers Squibb BMY Common Stock ⚑ Pharmaceutical · Energy and Commerce | Mar 27, 2025 12 days to disclose | Flat·+0.0% +2.4% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 12, 2025 1.3y ago | Julie Johnson DHouseTexas-32 | ↑bought | Bristol-Myers Squibb BMY Common Stock | Jan 15, 2025 28 days to disclose | Bad buy·−$207-2.6% −8.2% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 6, 2025 1.4y ago | Virginia Foxx RHouseNorth Carolina-05 | ↑bought | Bristol-Myers Squibb BMY Common Stock ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Dec 6, 2024 31 days to disclose | Bad buy·−$633-7.9% −10.8% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 2, 2024 1.8y ago | John James RHouseMichigan-10 | ↓sold | Bristol-Myers Squibb BMY Common Stock ⚑ Pharmaceutical · Energy and Commerce | Jan 18, 2024 228 days to disclose · 183 past 45-day window | Flat·+0.0% +6.6% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 2, 2024 1.8y ago | John James RHouseMichigan-10 | ↑bought | Bristol-Myers Squibb BMY Common Stock ⚑ Pharmaceutical · Energy and Commerce | Nov 10, 2023 297 days to disclose · 252 past 45-day window | Good buy·+$644+8.1% −9.6% vs S&P 500 | $1K-$15K midpoint $8K |
May 15, 2024 2.1y ago | Tommy Tuberville RSenateAlabama | ↓sold | Bristol-Myers Squibb BMY ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Apr 3, 2024 42 days to disclose | Missed gain·−$1K-12.5% +24.9% vs S&P 500 | $1K-$15K midpoint $8K |
May 15, 2024 2.1y ago | Tommy Tuberville RSenateAlabama | ↑bought | Bristol-Myers Squibb BMY Option⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Apr 3, 2024 42 days to disclose | Good buy·+$1K+12.5% −24.9% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 14, 2024 2.3y ago | Tommy Tuberville RSenateAlabama | ↓sold | Bristol-Myers Squibb BMY ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Jan 3, 2024 42 days to disclose | Missed gain·−$981-12.3% +40.0% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 19, 2024 2.4y ago | Rick Larsen DHouseWashington-02 | ↓sold | Bristol-Myers Squibb BMY | Jan 9, 2024 10 days to disclose | Flat·+0.0% +5.8% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 15, 2023 2.5y ago | Tommy Tuberville RSenateAlabama | ↓sold | Bristol-Myers Squibb BMY Option⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Nov 16, 2023 29 days to disclose | Flat·+0.0% +61.9% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 16, 2023 2.5y ago | Tommy Tuberville RSenateAlabama | ↑bought | Bristol-Myers Squibb BMY ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Oct 17, 2023 30 days to disclose | Bad buy·−$220-2.7% −16.1% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 9, 2023 2.6y ago | Greg Stanton DHouseArizona-04 | ↓sold | Bristol-Myers Squibb BMY | Oct 24, 2023 16 days to disclose | Flat·+0.0% +16.3% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 9, 2023 2.6y ago | Greg Stanton DHouseArizona-04 | ↑bought | Bristol-Myers Squibb BMY | Sep 26, 2023 44 days to disclose | Bad buy·−$527-6.6% −21.0% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 22, 2023 2.7y ago | Dan Sullivan RSenateAlaska | ↓sold | Bristol-Myers Squibb BMY ⚑ Pharmaceutical · Commerce, Science, and Transportation | Aug 22, 2023 31 days to disclose | Smart sell·+$407+5.1% +68.0% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 18, 2023 2.7y ago | Dan Sullivan RSenateAlaska | ↓sold | Bristol-Myers Squibb BMY ⚑ Pharmaceutical · Commerce, Science, and Transportation | Aug 22, 2023 27 days to disclose | Smart sell·+$407+5.1% +68.0% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2023 2.8y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Bristol-Myers Squibb BMY | Jul 12, 2023 32 days to disclose | Flat·+0.0% +14.5% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jun 14, 2023 3.0y ago | Shelley Moore Capito RSenateWest Virginia | ↓sold | Bristol-Myers Squibb BMY ⚑ Pharmaceutical · Commerce, Science, and Transportation | May 10, 2023 35 days to disclose | Smart sell·+$1.1K+14.3% +87.2% vs S&P 500 | $1K-$15K midpoint $8K |
May 26, 2023 3.0y ago | Rick Larsen DHouseWashington-02 | ↑bought | Bristol-Myers Squibb BMY | Nov 25, 2020 912 days to disclose · 867 past 45-day window | price pending | $1K-$15K midpoint $8K |
May 19, 2023 3.0y ago | Daniel S. Goldman DHouseNew York-10 | ↑bought | Bristol-Myers Squibb BMY | Apr 10, 2023 39 days to disclose | Bad buy·−$16.6K-22.2% −33.5% vs S&P 500 | $50K-$100K midpoint $75K |
Apr 17, 2023 3.1y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Bristol-Myers Squibb BMY | Mar 7, 2023 41 days to disclose | Flat·+0.0% +16.9% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 17, 2023 3.1y ago | Daniel S. Goldman DHouseNew York-10 | ↓sold | Bristol-Myers Squibb BMY | Mar 6, 2023 42 days to disclose | Flat·+0.0% +15.0% vs S&P 500 | $100K-$250K midpoint $175K |
Feb 13, 2023 3.3y ago | Dan Sullivan RSenateAlaska | ↓sold | Bristol-Myers Squibb BMY ⚑ Pharmaceutical · Commerce, Science, and Transportation | Jan 10, 2023 34 days to disclose | Smart sell·+$1.4K+18.1% +100.8% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 26, 2022 3.4y ago | Nicholas V. Taylor —HouseTexas-03 | ↓sold | Bristol-Myers Squibb BMY | Nov 28, 2022 28 days to disclose | Flat·+0.0% +9.1% vs S&P 500 | $100K-$250K midpoint $175K |
Dec 19, 2022 3.5y ago | Thomas R. Suozzi DHouseNew York-03 | ↓sold | Bristol-Myers Squibb BMY 2000084729 Bristol-Myers Squibb Company ⚑ Pharmaceutical · Ways and Means | Jun 7, 2021 560 days to disclose · 515 past 45-day window | Flat·+0.0% +21.2% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 19, 2022 3.5y ago | Thomas R. Suozzi DHouseNew York-03 | ↓sold | Bristol-Myers Squibb BMY 2000084726 Bristol-Myers Squibb Company ⚑ Pharmaceutical · Ways and Means | Jun 4, 2021 563 days to disclose · 518 past 45-day window | Flat·+0.0% +21.6% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 19, 2022 3.5y ago | Thomas R. Suozzi DHouseNew York-03 | ↓sold | Bristol-Myers Squibb BMY ⚑ Pharmaceutical · Ways and Means | Jul 30, 2020 872 days to disclose · 827 past 45-day window | price pending | $1K-$15K midpoint $8K |
Dec 19, 2022 3.5y ago | Thomas R. Suozzi DHouseNew York-03 | ↓sold | Bristol-Myers Squibb BMY ⚑ Pharmaceutical · Ways and Means | Jul 10, 2020 892 days to disclose · 847 past 45-day window | price pending | $1K-$15K midpoint $8K |
Dec 19, 2022 3.5y ago | Thomas R. Suozzi DHouseNew York-03 | ↓sold | Bristol-Myers Squibb BMY 2000084548 Bristol-Myers Squibb Company ⚑ Pharmaceutical · Ways and Means | Jan 9, 2020 1075 days to disclose · 1030 past 45-day window | price pending | $15K-$50K midpoint $32.5K |
Dec 19, 2022 3.5y ago | Thomas R. Suozzi DHouseNew York-03 | ↓sold | Bristol-Myers Squibb BMY 2000084402 Bristol-Myers Squibb Company ⚑ Pharmaceutical · Ways and Means | Apr 8, 2019 1351 days to disclose · 1306 past 45-day window | price pending | $1K-$15K midpoint $8K |
Dec 19, 2022 3.5y ago | Thomas R. Suozzi DHouseNew York-03 | ↓sold | Bristol-Myers Squibb BMY ⚑ Pharmaceutical · Ways and Means | Mar 29, 2019 1361 days to disclose · 1316 past 45-day window | price pending | $1K-$15K midpoint $8K |
Dec 19, 2022 3.5y ago | Thomas R. Suozzi DHouseNew York-03 | ↑bought | Bristol-Myers Squibb BMY ⚑ Pharmaceutical · Ways and Means | Apr 17, 2018 1707 days to disclose · 1662 past 45-day window | price pending | $1K-$15K midpoint $8K |
Sep 2, 2022 3.8y ago | Carol D. Miller RHouseWest Virginia-01 | ↓sold | Bristol-Myers Squibb BMY ⚑ Pharmaceutical · Ways and Means | Nov 10, 2021 296 days to disclose · 251 past 45-day window | Smart sell·+$372+1.1% +55.1% vs S&P 500 | $15K-$50K midpoint $32.5K |
Aug 10, 2022 3.8y ago | Kathy Manning DHouseNorth Carolina-06 | ↑bought | Bristol-Myers Squibb BMY | Jul 15, 2022 26 days to disclose | Bad buy·−$2.2K-27.7% −41.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 15, 2022 3.9y ago | Shelley Moore Capito RSenateWest Virginia | ↓sold | Bristol-Myers Squibb BMY ⚑ Pharmaceutical · Commerce, Science, and Transportation | Jun 17, 2022 28 days to disclose | Smart sell·+$1.6K+20.4% +110.8% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 19, 2022 4.1y ago | John H. Rutherford RHouseFlorida-05 | ↓sold | Bristol-Myers Squibb BMY | Mar 16, 2022 34 days to disclose | Flat·+0.0% +10.8% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 3, 2022 4.3y ago | Thomas R Carper DSenateDelaware | ↑bought | Bristol-Myers Squibb BMY | Jan 18, 2022 16 days to disclose | Bad buy·−$762-9.5% −65.9% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 4, 2021 4.5y ago | Thomas R Carper DSenateDelaware | ↑bought | Bristol-Myers Squibb BMY | Nov 29, 2021 5 days to disclose | Good buy·+$596+7.4% −46.2% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 4, 2021 4.6y ago | John A. Yarmuth —HouseKentucky-03 | ↑bought | Bristol-Myers Squibb BMY | Sep 23, 2021 42 days to disclose | Bad buy·−$784-9.8% −21.9% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 4, 2021 4.6y ago | John A. Yarmuth —HouseKentucky-03 | ↑bought | Bristol-Myers Squibb BMY | Sep 22, 2021 43 days to disclose | Bad buy·−$727-9.1% −22.0% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 23, 2021 4.7y ago | Thomas R. Suozzi DHouseNew York-03 | ↓sold | Bristol-Myers Squibb BMY ⚑ Pharmaceutical · Ways and Means | Jun 7, 2021 108 days to disclose · 63 past 45-day window | Flat·+0.0% +21.2% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 23, 2021 4.7y ago | Thomas R. Suozzi DHouseNew York-03 | ↓sold | Bristol-Myers Squibb BMY ⚑ Pharmaceutical · Ways and Means | Jun 4, 2021 111 days to disclose · 66 past 45-day window | Flat·+0.0% +21.6% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 23, 2021 4.7y ago | Thomas R. Suozzi DHouseNew York-03 | ↓sold | Bristol-Myers Squibb BMY ⚑ Pharmaceutical · Ways and Means | Jan 9, 2020 623 days to disclose · 578 past 45-day window | price pending | $15K-$50K midpoint $32.5K |
Sep 23, 2021 4.7y ago | Thomas R. Suozzi DHouseNew York-03 | ↑bought | Bristol-Myers Squibb BMY ⚑ Pharmaceutical · Ways and Means | Jan 9, 2020 623 days to disclose · 578 past 45-day window | price pending | $50K-$100K midpoint $75K |
Sep 23, 2021 4.7y ago | Thomas R. Suozzi DHouseNew York-03 | ↓sold | Bristol-Myers Squibb BMY ⚑ Pharmaceutical · Ways and Means | Apr 8, 2019 899 days to disclose · 854 past 45-day window | price pending | $15K-$50K midpoint $32.5K |
Sep 23, 2021 4.7y ago | Thomas R. Suozzi DHouseNew York-03 | ↑bought | Bristol-Myers Squibb BMY ⚑ Pharmaceutical · Ways and Means | Oct 1, 2018 1088 days to disclose · 1043 past 45-day window | price pending | $15K-$50K midpoint $32.5K |
Aug 13, 2021 4.8y ago | Tommy Tuberville RSenateAlabama | ↑bought | Bristol-Myers Squibb BMY ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Jul 16, 2021 28 days to disclose | price pending | $15K-$50K midpoint $32.5K |
May 2, 2021 5.1y ago | DJ David A Perdue , Jr —Senate | ↓sold | Bristol-Myers Squibb BMY | Apr 16, 2020 381 days to disclose · 336 past 45-day window | price pending | $1K-$15K midpoint $8K |
May 2, 2021 5.1y ago | DJ David A Perdue , Jr —Senate | ↓sold | Bristol-Myers Squibb BMY | Apr 14, 2020 383 days to disclose · 338 past 45-day window | price pending | $15K-$50K midpoint $32.5K |
May 2, 2021 5.1y ago | DJ David A Perdue , Jr —Senate | ↓sold | Bristol-Myers Squibb BMY | Apr 14, 2020 383 days to disclose · 338 past 45-day window | price pending | $15K-$50K midpoint $32.5K |